We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Investigating the interplay of the immune system, skin barrier, and microbiome following dermal exposure to triclosan
Summary
This study investigated how triclosan, an antimicrobial chemical in skin care products, disrupts the skin barrier, skin microbiome, and immune system following direct skin exposure in mice. Triclosan exposure has been linked to increased allergy and asthma risk in humans, and understanding its mechanism is relevant to evaluating safety of chemicals in personal care products.
Triclosan is an antimicrobial chemical used in healthcare products that are applied to the skin. However, exposure to triclosan has been positively associated with food allergy, aeroallergy, and asthma severity in humans. In mice, dermal triclosan exposure, although not directly sensitizing, has been shown to augment the allergic response in a model of asthma. Furthermore, exposure to triclosan on mouse skin has been demonstrated to be immunomodulatory through the activity of thymic stromal lymphopoietin and S100 calcium-binding protein A8. The skin barrier and microbiome are known to interact with the immune system and disruptions in barrier integrity and the microbiome are associated with allergic diseases. However, the impact of dermal triclosan exposure on the skin integrity, skin microbiome, and its interplay with the immune system has not been evaluated. In these studies, dermal exposure to triclosan was evaluated using a mouse model and a model of reconstructed human epidermis. In mice, repeated (7-day) dermal exposure to 2% triclosan increased transepidermal water loss, altered the expression patterns of skin barrier genes, and changed the composition of the skin and gut microbiome. In a model of reconstructed human epidermis, exposure to 0.2% triclosan increased skin permeability, altered the expression of skin barrier genes, and increased the production of proinflammatory cytokines. Taken together, these results suggest that exposure to triclosan disrupts the skin barrier integrity and microbiome and that these alterations may influence immune responses. A better understanding of immunomodulation and its contribution to the development of allergic disease is needed to aid in the prevention and treatment of disease.
Sign in to start a discussion.
More Papers Like This
Effect of altered human exposome on the skin and mucosal epithelial barrier integrity.
This review examined how modern environmental exposures including microplastics, air pollutants, and chemical toxicants disrupt the epithelial barrier integrity of skin and mucous membranes, arguing that the 'exposome' of chronic low-level chemical exposures is a major but underappreciated driver of barrier dysfunction and associated inflammatory diseases.
Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases
This review summarizes how the protective barriers of our skin, gut, and lungs can be damaged by environmental factors including microplastics, leading to allergic conditions like asthma, food allergies, and eczema. The authors explain that a person's genetics, microbiome, and environmental exposures all contribute to barrier breakdown, and they highlight current treatments as well as gaps in care for these increasingly common conditions.
Emerging mechanisms of microplastic-induced skin diseases: a perspective from the gut–skin axis
This review examined the emerging mechanisms by which microplastics may contribute to skin diseases through the gut-skin axis. Researchers found evidence that microplastics can induce gut microbiota dysbiosis and compromise intestinal barrier integrity, which in turn may impair skin barrier function and trigger inflammatory skin conditions through shared immunological and neuroendocrine pathways.
Emerging mechanisms of microplastic-induced skin diseases: a perspective from the gut–skin axis
This review examined the emerging mechanisms by which microplastics may contribute to skin diseases through the gut-skin axis. Researchers found evidence that microplastics can induce gut microbiota dysbiosis and compromise intestinal barrier integrity, which in turn may impair skin barrier function and trigger inflammatory skin conditions through shared immunological and neuroendocrine pathways.
Emerging mechanisms of microplastic-induced skin diseases: a perspective from the gut–skin axis
This review explores how microplastics may cause skin damage through the gut-skin axis, a system connecting intestinal and skin health through immunological and neuroendocrine pathways. The study suggests that microplastics can disrupt gut microbial balance and intestinal barrier integrity, allowing harmful bacteria and metabolites to enter the bloodstream and contribute to skin inflammation, metabolic imbalance, and oxidative stress.